IRadimed
IRMD | NASDAQ
$84.84
-$0.51 (-0.60%)
At close: Nov 16, 2026, 4:00 PM ET
$85.85
+$1.01 (+1.19%)
After-hours:
Nov 16, 2026, 7:32 PM ET
IRadimed Company Profile
Company profile explainedCompany Profile
IRADIMED CORPORATION specializes in the engineering, production, and distribution of medical devices specifically designed for compatibility with magnetic resonance imaging (MRI) environments. The company supplies these specialized products, alongside their related accessories and support services, to both U.S. and international markets. Key offerings include the MRidium MRI-compatible intravenous (IV) infusion pump system, which comes with disposable tubing sets, and an MRI-compatible patient vital signs monitoring system. Furthermore, IRADIMED provides a range of complementary items such as non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring solutions with sensors. Their clientele primarily consists of hospitals, acute care facilities, and outpatient imaging centers. Sales are conducted via direct field representatives, regional sales directors, clinical support specialists, and independent distributors. Founded in 1992, IRADIMED CORPORATION is headquartered in Winter Springs, Florida.
Key Executives
| Name | Position |
|---|---|
| Roger E. Susi | Founder, Chairman, Chief Executive Officer & President |
| John F. Glenn | Chief Financial Officer & Corporate Secretary |
| Chris Williamson | Executive Vice President of Continuous Improvement & Information Technology |
| Jeff Chiprin | Chief Commercial Officer |
| Lynn Neuhardt | Vice President of Research & Development |
| Matt Garner | Controller |
| Randy Waddell | Vice President of Worldwide Sales & Marketing |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 30, 2026 | 10-Q | Quarterly Report |
| Oct 30, 2026 | 8-K | Current Report |
| Oct 27, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Sep 25, 2026 | 4 | Filing |
| Sep 08, 2026 | 4 | Filing |
| Aug 18, 2026 | 8-K/A | [Amend] Current Report |
| Jul 31, 2026 | 10-Q | Quarterly Report |
| Jul 31, 2026 | 8-K | Current Report |
| Jul 28, 2026 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Jun 24, 2026 | 8-K | Current Report |
IRadimed
| Country | United States |
| IPO Date | Jul 16, 2014 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 166 |
| CEO | Roger E. Susi |
Contact Details
1025 Willa Springs Drive Orlando,
Florida 32826 United States
Stock Details
| Ticker Symbol | IRMD |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001325618 |
| CUSIP Number | 46266A109 |
| ISIN Number | US46266A1097 |
| SIC Code | 3841 |
Recent News
- 18 days ago / marketbeat.comWhat iRadimed (IRMD) Said on Its Q3 Earnings Call
- 18 days ago / seekingalpha.comIRADIMED CORPORATION (IRMD) Q3 2026 Earnings Call Transcript
- 18 days ago / globenewswire.comIRADIMED CORPORATION Reports Third Quarter 2026 Financial Results
- 25 days ago / globenewswire.comIRADIMED CORPORATION to Hold Third Quarter 2026 Financial Results Conference Call on October 30, 2026
- 2 months ago / globenewswire.comIRADIMED CORPORATION To Participate in the 5th Annual ROTH Healthcare Opportunities Conference
- 2 months ago / gurufocus.comiRadimed Corp (IRMD) Stock Down 3.8% but Still Overvalued -- GF Score: 92/100
- 4 months ago / marketbeat.comiRadimed Q2 Earnings Call Highlights
- 4 months ago / seekingalpha.comIRADIMED CORPORATION (IRMD) Q2 2026 Earnings Call Transcript
- 4 months ago / globenewswire.comIRADIMED CORPORATION Reports Second Quarter 2026 Financial Results
- 4 months ago / globenewswire.comIRADIMED CORPORATION to Hold Second Quarter 2026 Financial Results Conference Call on July 31, 2026
Add to Watchlist
Select watchlists to add or remove IRMD